Alzheimer's Disease & Dementia FAQ
Alzheimer's Disease & Dementia FAQ
The questions that actually determine whether an international assessment is worth doing are not clinical ones. They are about what it costs and why that depends on the records, whether the person has to travel, how long it takes, what to send, whether insurance will pay, and what happens once you are home. This page answers each of them in the order families ask them, including the two that most services avoid: why there is no price before the records are seen, and why the person usually has to come.
What it costs
The initial assessment is free: records sent ahead are reviewed without charge, and the written opinion — including whether being assessed here would add anything to the care you already receive — comes back before any payment is discussed. That ordering is deliberate. A large share of the enquiries we receive are answered in that letter, and no travel follows.
Where assessment or treatment here is appropriate, complete care in China typically runs at 30–50% of comparable care in Europe or the United States, consistently across conditions and programmes. For a dementia assessment the components are the consultation and the cognitive testing, the blood work directed at the reversible causes, the imaging, and where it will change management the biomarker testing — amyloid PET or cerebrospinal fluid measurement. Where anti-amyloid antibody treatment is a live question, that is a separate and considerably larger cost, and it is quoted separately rather than bundled.
| Situation | What is needed | Effect on cost |
|---|---|---|
| Exclusion work already complete | A second opinion, the pattern reviewed, and one directed question answered | The least expensive pathway, and the commonest one that is still worth travelling for |
| A label, but no exclusion work | The full sequence: blood tests, medicines review, imaging, cognitive testing | Materially more, because the part that has the most value has not been done |
| Atypical or young-onset presentation | Adds advanced imaging and, usually, biomarker testing | Higher, and justified when the result will change management — which is the test we apply before ordering it |
| Antibody eligibility being assessed | Confirmatory biomarker testing, APOE assessment, and the monitoring schedule arranged | Substantial and separate; quoted with the infusion and scan schedule itemised rather than as a package |
An itemised quotation is provided once the records define what is actually needed. What this page will not do is give a price without that, because a single number would have to be the most expensive pathway and would therefore be wrong for most people.
How long the visit takes
This is stated in the written plan before anything is booked, because it depends on what the assessment turns up rather than on a standard package. An assessment built around consultation, cognitive testing, blood work and imaging is arranged as outpatient visits and can be completed in a short stay. Where formal neuropsychological testing, a sleep study or biomarker testing is added, extra days are built in rather than squeezed in.
Because dementia is followed over years rather than treated in a week, most people do not stay for a course of treatment. The usual arrangement is one focused visit that answers the questions that are actually open — is the diagnosis right, what has not been excluded, what should the plan be — followed by monitoring at home against the targets written in the plan.
Two things make the stay easier and are worth arranging before the flights. Bring one person who knows the person well and can describe what they have observed; their account is part of the assessment rather than a courtesy. And keep the day simple while you are here — an unfamiliar hotel, a long day of appointments and a disrupted routine will all make the person perform worse than they do at home, and a cognitive assessment taken on a bad travel day is a worse assessment.
What to send, and what it answers
Six categories determine most of the value of the opinion, and none of them needs translating except what our coordinators handle. Reports are more useful than summaries, and dates matter more than either.
| What to send | What it answers |
|---|---|
| Clinic letters, including the earliest one | What was noticed first, when, and how the picture has been described since — the sequence is itself evidence |
| Cognitive testing, with the scores and the dates | Whether there is documented decline and what the trajectory is. A score without a date is close to useless |
| Imaging reports, and the images where you have them | The pattern of atrophy, the vascular burden, and whether hydrocephalus or a structural cause has been considered |
| Blood test results | Whether the reversible causes have been covered, and which ones have not |
| Every current medicine, including over-the-counter | The anticholinergic and sedative burden, which is the highest-yield finding available |
| A note from a family member | What they have observed, what they have quietly taken over, and when — the most reliable functional measure there is |
The item most often missing is the last one, and it is usually the most useful. A short paragraph from someone who sees the person daily — what changed first, what has stopped being done, what time of day is hardest — carries more weight than a normal scan.
When to travel, and when not to
The right time to travel is when there is an open question that travelling would close, and the wrong time is when the question is already answered or when the journey itself would do harm.
| Situation | What we would say |
|---|---|
| An open diagnostic question | Worth coming. An atypical presentation, a young onset, or a biomarker question that has not been settled is exactly what a compressed pathway closes |
| The exclusion work has not been done | Worth coming, though much of it can be arranged locally first — and we will say so rather than sell the journey |
| A second opinion on a settled plan | Often best done from the records alone. We will tell you when that is the case |
| Recent delirium, infection, or an unsettled hospital admission | Not now. Travel during an acute change makes the assessment uninterpretable and the journey harder than it needs to be |
| Advanced disease with significant behavioural symptoms | Usually not. An unfamiliar environment reliably makes things worse, and there is rarely a question left that travelling would answer |
| Travelling alone, or with an unfamiliar carer | Not advisable. The companion is part of the assessment and part of the safety plan |
One caution that is specific to this illness: a hospital admission or a change of environment produces a step down that may not fully recover. If someone has been recently admitted, or has had a delirium in the last few weeks, the assessment should wait until they are back to their own baseline — otherwise what gets measured is the delirium rather than the dementia.
Insurance, and what is usually excluded
More than thirty international insurers settle directly with us, which means no payment up front and no claim to make afterwards. Whether a particular policy covers this, however, depends on the policy rather than on the treatment, and three exclusions recur.
| Item | What usually happens |
|---|---|
| Assessment and diagnostics | Often covered where the policy covers outpatient specialist care, and pre-authorisation is required |
| Chronic and pre-existing conditions | A common exclusion. A dementia diagnosed before the policy began is frequently excluded outright |
| Anti-amyloid antibody treatment | Usually authorised separately, and frequently excluded as an unproven or experimental therapy depending on the policy and the jurisdiction |
| The monitoring scans | A distinct and recurring cost, and one families underestimate. Authorised separately from the treatment |
| Long-term care and respite | Almost always excluded from medical policies, and a separate arrangement entirely |
Our team will tell you in writing what your policy is likely to cover and what it will not, before anything is booked. Where the answer is that it is not covered, we will say so rather than let you discover it in a claim.
After you go home
The useful output of a visit is not a procedure. It is a written plan that your local team can execute, and it is worth being specific about what that contains.
| What you receive | Who needs it |
|---|---|
| A written summary in English: the diagnosis, what supports it, and what remains open | Your local neurologist or geriatrician, and the family |
| The exclusion list, with what has been covered and what has not | Your local team, so the remaining items can be completed at home |
| The medicines, with what each is for and what to watch | Your local prescriber, and the pharmacist |
| What is being measured, and at what interval | Whoever follows the person — usually a local clinician and the family together |
| What should trigger a change, and who to call | The family, and the caregiver. This is the page that gets used |
| A named contact for written questions afterwards | Your local team, when a question arises that the plan does not cover |
Two practical points that make the difference between a plan that is used and one that is filed. Monitoring at home is done against the targets written in the plan rather than against an impression, which is why the plan states what is being measured and how often. And continuity of medicines matters: the formulations available in China are not always identical to those at home, so the summary lists the generic name and the dose rather than a brand, and any change is made by the local prescriber rather than by the family comparing boxes.
Who should come, and why it matters
The person who comes with the patient is not an escort. They are the most important piece of clinical information in the room, and in this illness that is more true than in almost any other.
| Role | Why it cannot be done from the records |
|---|---|
| Giving the history | What changed first, when, and how fast is something only they can describe, and it is the most informative part of the assessment |
| Describing the adaptations | What they have quietly taken over, and when, is the most reliable functional measure available and is almost never volunteered |
| Being present during testing | Their presence reduces distress, and their account of how the person managed in the hotel is itself data |
| Hearing the plan | Two people hear more than one from a consultation, and the plan is executed by the companion rather than by the patient |
| Safety during the journey | Unfamiliar airports, hotels and clinics are the settings in which wandering and agitation occur |
| Making the decisions afterwards | The person appointed to decide is the one who needs to have heard the reasoning first-hand |
Practical advice for the journey, because this is where it usually goes wrong: bring the person's own medicines in their original packaging, keep the daily routine as close to home as possible, carry a short written note in English with the diagnosis and the medicines in case of an emergency, and do not schedule sightseeing around the appointments. A person with dementia who is overtired and in an unfamiliar hotel will test worse than they are, and the assessment is the reason you came.